{
    "2020-07-21": [
        [
            {
                "time": "2020-08-15",
                "original_text": "康泰生物点评报告：四联苗高速放量，研发管线持续推进",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "四联苗",
                        "研发管线",
                        "高速放量"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-07-20",
                "original_text": "基金二季度持仓路线曝光，这些板块仍是配置重点（附股）",
                "features": {
                    "keywords": [
                        "基金",
                        "二季度",
                        "持仓",
                        "医药",
                        "科技"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-10",
                "original_text": "康泰生物2020半年报点评：二季度高增长 管线值得期待",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "半年报",
                        "二季度",
                        "高增长",
                        "管线"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-05",
                "original_text": "康泰生物：四联苗和23价肺炎疫苗贡献增量 全年业绩增长可期",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "四联苗",
                        "23价肺炎疫苗",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-25",
                "original_text": "69只股股价创历史新高",
                "features": {
                    "keywords": [
                        "股价",
                        "历史新高"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-15",
                "original_text": "明星基金经理调仓换股！医药、科技持续受关注",
                "features": {
                    "keywords": [
                        "基金经理",
                        "调仓换股",
                        "医药",
                        "科技"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-20",
                "original_text": "康泰生物：上半年业绩恢复理想 全年高速增长值得期待",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "上半年",
                        "业绩恢复",
                        "全年增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-10",
                "original_text": "创新药板块午后再度拉升，人福医药、智飞生物双双涨停",
                "features": {
                    "keywords": [
                        "创新药",
                        "拉升",
                        "人福医药",
                        "智飞生物",
                        "涨停"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-28",
                "original_text": "康泰生物2020半年报点评：行业景气度提升 二季度收入高速增长",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "半年报",
                        "行业景气度",
                        "二季度",
                        "收入增长"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-12",
                "original_text": "康泰生物：2020年上半年营业收入8.7亿元，归母净利润2.6亿元",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "营业收入",
                        "归母净利润",
                        "上半年"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}